NASBA® factor V Leiden QL; a new genotype assay to detect the factor V Leiden mutation in anticoagulated whole blood

Fibrinolysis

Volumn 10, Issue SUPPL. 2, 1996, Pages 31-32

  Roeles, F ^a   Kok, W ^a   Top, B ^a   Adriaanse, H ^a   Tacken, N ^a   Van Gemen, B ^a  

^a Organon Teknika   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN;

ASSAY; BLOOD CLOTTING DISORDER; CONFERENCE PAPER; HUMAN; PRIORITY JOURNAL; PROTEIN C DEFICIENCY;

EID: 0029906083     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(96)80042-7     Document Type: Conference Paper

References (3)

1. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant respons to activated protein C. Proc.Nat.Acad.Sci. 1993; 90, 1004-1008.
2. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation Factor V associated with resistance to activated protein C. Nature 1994; 369, 64-67.
3. Shen NLL, et al. The serine protease cofactor Factor V is synthesized by lymphocytes. J. Immunol. 1993; 150, 2992-3001